Stay updated on Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The record history now shows a new site revision entry labeled v3.7.0. The previous revision v3.6.6 is removed, updating the history to reflect the latest site revision.
    Difference
    0.1%
    Check dated 2026-09-20T20:04:27.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page's Revision label changed from v3.6.5 to v3.6.6, indicating a new build of the page. This reflects an internal update without altering the study history or content.
    Difference
    0.1%
    Check dated 2026-08-30T08:13:15.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.5) was added to the history and the prior entry (v3.6.4) was removed, indicating an update to the record's revision history.
    Difference
    0.1%
    Check dated 2026-08-08T23:31:28.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The study history now includes revision v3.6.4, replacing the previous v3.6.3. This indicates a small update to the record metadata rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-07-25T17:38:37.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    A new Study Status entry was added on 2026-07-06 (with a related date marker 2026-07-01 and index 32). An older entry dated 2025-05-13 was removed.
    Difference
    0.3%
    Check dated 2026-07-11T14:14:03.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now listed as the latest revision in the study history, replacing v3.6.2. This indicates a minor update to the page’s revision tracking rather than changes to core study content.
    Difference
    0.1%
    Check dated 2026-07-04T08:08:39.000Z thumbnail image

Stay in the know with updates to Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.